← All stocks

Broadridge Financial Solutions

BR Net selling
CIK 0001383312 #78 in the set updated 17 Sep 2026
Bought (12 mo)
$1.03M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$3.60M
$0.00 on a plan · $2.34M straight out of an exercise
Sold at will
$1.25M
3 of 6 sales
Net
−$2.56M
−$223.04K against sales at will

By person

19 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Carey Thomas P
Corporate VP
$2.34M (3) scheduled
−$2.34M
11,301
0.0099%
$1.75M
−21.9%
Gokey Timothy C
CEO
$1.03M (1)
+$1.03M
176,141
0.1545%
$27.30M
−14.6%
PERRY CHRISTOPHER JOHN
President
$900.38K (1)
−$900.38K
54,137
0.0475%
$8.39M
+7.8%
Jarkowski Hope M.
Chief Legal Officer
$304.72K (1)
−$304.72K
1
<0.0001%
$193.74
0.0%
Duelks Robert N
Director
$48.73K (1)
−$48.73K
38,085
0.0334%
$5.90M
+19.3%
DALY RICHARD J
Executive Chairman
103,490
0.0908%
$16.04M
−1.5%
BRUN LESLIE A
Director
77,433
0.0679%
$12.00M
+0.1%
Markus Maura A.
Director
32,718
0.0287%
$5.07M
+31.1%
DESCHUTTER DOUGLAS RICHARD
Co-President ICS
18,047
0.0158%
$2.80M
−46.2%
keller brett
Director
16,968
0.0149%
$2.63M
+50.3%
Nazareth Annette L.
Director
9,614
0.0084%
$1.49M
+162.8%
Zavery Amit
Director
9,011
0.0079%
$1.40M
+35.8%
Stingi Richard John
Corporate VP and CHRO
7,681
0.0067%
$1.19M
+17.6%
Carter Pamela L
Director
7,282
0.0064%
$1.13M
+56.6%
Matlin Laura
CVP, Deputy GC and CCO
6,343
0.0056%
$983.09K
+3.7%
Ghei Ashima
CFO
6,027
0.0053%
$934.15K
+69.4%
MURRAY EILEEN K
Director
5,758
0.0050%
$892.46K
+164.0%
FLOWERS MELVIN L
Director
2,694
0.0024%
$417.56K
+59.0%
Mosconi Patricia Ann
Director
641
0.0006%
$99.35K
+6,310%
Insider
Date
Role
Action
Shares
Price
Amount
Jarkowski Hope M.
4 Jun 2026
Chief Legal Officer
Sell
1,966
$155.00
$304.72K
Duelks Robert N
6 Feb 2026
Director
Sell
253
$192.60
$48.73K
PERRY CHRISTOPHER JOHN
18 Nov 2025
President
Sell
3,984
$226.00
$900.38K

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 119,331
History held since 31 Aug 2016